N- (2-benzyl) -2-phenylbutanamides as androgen receptor modulators

Details for Australian Patent Application No. 2005251766 (hide)

Owner Merck & Co., Inc.

Inventors Hanney, Barbara; Meissner, Robert S.; Wang, Jiabing; Krout, Michael R.; Perkins, James J.; Mitchell, Helen J.; Kim, Yuntae; Musselman, Jeffrey

Agent Spruson & Ferguson

Pub. Number AU-B-2005251766

PCT Pub. Number WO2005/120477

Priority 60/577,698 07.06.04 US

Filing date 3 June 2005

Wipo publication date 22 December 2005

Acceptance publication date 15 January 2009

International Classifications

C07D 213/61 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

A61K 31/00 (2006.01)

C07C 233/13 (2006.01) Carboxylic acid amides

C07C 235/34 (2006.01) Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms

C07C 271/12 (2006.01) Derivatives of carbamic acid, i.e. compounds containing any of the groups the nitrogen atom not being part of nitro or nitroso groups

C07D 295/205 (2006.01) Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms

Event Publications

4 January 2007 PCT application entered the National Phase

  PCT publication WO2005/120477 Priority application(s): WO2005/120477

15 January 2009 Application Accepted

  Published as AU-B-2005251766

14 May 2009 Standard Patent Sealed

21 January 2010 Amendment Made

  The nature of the amendment is: Amend patentee name from Merck & Co., Inc. to Merck Sharp & Dohme Corp.

11 October 2012 Alteration of Name

  The name of the patentee has been altered to Merck Sharp & Dohme Corp.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005251769-Cancer treatment method

2005251764-Method for treating lupus